United States. Department of Health and Human Services. Office of the Assistant Secretary for Planning and Evaluation. Office of Behavioral Health, Disability, and Aging Policy, issuing body.
Publication:
Washington, D.C. : Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, Office of Behavioral Health, Disability, and Aging Policy, January 2022
Over the past two decades, the United States has experienced a public health crisis related to substance use disorders (SUDs). This crisis is especially pronounced with regard to opioid use disorders (OUDs), to which women are increasingly vulnerable. Between 1999 and 2016, the rate of deaths from prescription opioid overdoses increased 507% among women, compared with an increase of 321% among men. Also, between 1999 and 2014, the national prevalence of OUDs among pregnant women increased 333%. This increase among women who are pregnant can have far-reaching impacts on quality of life and health care costs for mothers and their infants. Maternal SUDs can cause several birth-related complications that can increase hospital costs and length of stay. However, expanded insurance coverage and increased interaction with health care professionals during pregnancy provide opportunities to link pregnant women experiencing SUDs to treatment services in order to reduce the impacts of SUDs on mother, child, and health care spending. This brief is based on findings from an environmental scan of peer-reviewed and grey literature and a technical expert panel meeting that RTI held on behalf of ASPE in July 2019 to discuss policies on integrating Obstetrics and Gynecology (OB/GYN) and SUD services.
Copyright:
The National Library of Medicine believes this item to be in the public domain. (More information)